In conclusion the study of CD30+ and CD30L+ cells helps in clarifying the complex pro- and anti-inflammatory mechanisms that take place in RA and possibly pave new avenues for the understanding of the response to therapy and envisage the possibility of novel treatments directed against the CD30L molecule. Here, TNFSF8 is linked to rheumatoid arthritis.